IGF-I contributes to the regulation of glomerular filtration and kidney growth, and its administration has been shown to improve renal function and has been proposed as a possible therapeutic agent for patients with chronic renal failure (Hirschberg and Adler, 1998). Here, IGF1 is linked to chronic kidney disease.